The peripheral blood mononuclear celi subsets in patients with Kawasaki disease and coronary artery lesions were investigated. Of the 106 patients 14 had lesions. Patients with Kawasaki disease and coronary artery lesions were found to have increased counts of CD14+ macrophages/monocytes compared
Patients and methods Inclusion in this study depended on patients meeting the diagnostic criteria for Kawasaki disease. Sixty five boys and 41 girls were included; they were aged 1-68 months (mean 22 months). The day of onset of fever was recognised as the first day of illness. Blood samples were taken for analysis of peripheral blood mononuclear cell subsets between the third to the ninth days after onset of illness (mean (SD) 5-8 (1 6) days) before treatment by intravenous gammaglobulin and aspirin or aspirin alone. Patients received aspirin 30 mg/kg/day in three divided doses up until the 30th day after the onset of fever. Of the 106 patients with Kawasaki disease, 60 received the same course of aspirin and in addition received an infusion of intravenous gammaglobulin (Venilon, Teijin Limited, Tokyo) in a 5% solution at a daily dosage of 200 mg/kg for five consecutive days. Sixty seven of the 106 patients with Kawasaki disease were sampled for peripheral blood mononuclear cell subsets on the ninth to 15th days (mean (SD), 11-5 (2-0) days) of illness, after treatment by intravenous gammaglobulin or during treatment by aspirin alone. Thirty six of the 67 patients with Kawasaki disease received aspirin and an infusion of intravenous gammaglobulin and the others received aspirin alone. In addition, 68 patients were examined for peripheral blood mononuclear cell subsets on the 20th to the 68th days (mean (SD) 33 
Results
During a 30 day period after the onset of the disease, 14 patients were shown to have coronary artery lesions. Eight of these 14 patients received aspirin and an infusion of intravenous gammaglobulin and the others received aspirin alone. during the acute stage preceding treatment compared with those found in control subjects (p<0-01 and p<005, respectively). The absolute counts of CD4+ and CD8+ T cells and CD57+ cells found in patients with Kawasaki disease decreased during the acute stage preceding treatment compared with those found in control subjects (p<005). These increased absolute counts of CD14+ macrophages/monocytes and CD19+ B cells and decreased absolute counts of CD4+ and CD8+ T cells, and CD57+ cells in patients with Kawasaki disease were seen to be within the normal range during the convalescent stage.
The absolute counts of CD 14+ macrophages/ monocytes in patients with coronary artery lesions were higher than those of patients without lesions during the acute stage before treatment (p<0-01). There were no significant differences in the absolute counts of CD3+., CD4+ and CD8+ T cells, CD57+ cells, and CD19+ B cells in patients with Kawasaki disease with and without lesions.
Eleven of the 14 patients with Kawasaki disease and lesions were examined for peripheral blood mononuclear cell subsets after treatment by intravenous gammaglobulin (n=6) or during treatment by aspirin alone (n= 5). Table 2 shows the absolute counts of white cells and CD14+ marcophages/monocytes of patients with and without lesions after treatment by intravenous gammaglobulin or aspirin alone during the acute stage. The absolute counts of CD14+ macrophages/monocytes found in patients with coronary artery lesions were high during the acute stage after treatment by intravenous gammaglobulin or aspirin alone compared with those found in control subjects (p<002). Patients with Kawasaki disease without lesions, treated with aspirin alone, had high absolute counts of CD14+ macrophages/monocytes compared with control subjects and those treated with intravenous gammaglobulin (p<001). There was no significant difference between the absolute counts of CD14+ macrophages/monocytes of patients without lesions treated with intravenous gammaglobulin and of control subjects.
Discussion
Treatment with intravenous gammaglobulin has been reported to be effective in reducing the incidence of coronary artery lesions in Kawasaki disease.8 Before the routine application of this treatment lesions developed in approximately 15% of patients with Kawasaki disease,9 while recently its incidence has decreased. Our study represents the first report on the determination of the numerical changes of immunocompetent cells in patients with Kawasaki disease and coronary artery lesions. Although several studies have been reported on the numerical changes of immunocompetent cells in patients with acute Kawasaki disease, those previous reports were based on the analysis of peripheral blood lymphocyte subsets.6 Here we analysed the peripheral blood mononuclear cell subsets including macrophages/monocytes in patients with Kawasaki disease with and without lesions.
The purpose of this study was to compare peripheral blood mononuclear cell subsets in patients with Kawasaki disease with and without coronary artery lesions, although we did not 
